← FDA Drug Approvals (Drugs@FDA)
RISPERIDONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NANOMI · Approved 2025-09-02
Drug application
- FDA Application #
ANDA211220- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RISPERIDONE
- Generic name
- RISPERIDONE
- Active ingredients
- RISPERIDONE
- Dosage form
- POWDER
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- NANOMI
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2025-09-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown